Cirrhosis future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Future or Investigational Therapies== | ==Future or Investigational Therapies== | ||
The following therapies are under trial: | |||
*Obeticholic acid (OCA) for patients with primary biliary cirrhosis. | |||
==Reference== | ==Reference== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 18:18, 6 September 2012
|
Cirrhosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case studies |
|
Cirrhosis future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Cirrhosis future or investigational therapies |
|
Risk calculators and risk factors for Cirrhosis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-In-Chief: Ujjwal Rastogi, M.B.B.S. [2]
Overview
Future or Investigational Therapies
The following therapies are under trial:
- Obeticholic acid (OCA) for patients with primary biliary cirrhosis.